Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019

Daniela Renedo(Yale University), Julián Acosta(Yale University), Audrey C. Leasure(Yale University), Richa Sharma, Harlan M. Krumholz(Yale New Haven Hospital), Adam de Havenon(Yale University), Fares Alahdab(Mayo Clinic), Aleksandr Y. Aravkin(University of Washington), Zahra Aryan(Brigham and Women's Hospital), Till Bärnighausen(Harvard University), Sanjay Basu(San Francisco General Hospital), Katrin Burkart(University of Washington), Kaleb Coberly(University of Washington), Michael H. Criqui(University of California San Diego), Xiaochen Dai(University of Washington), Rupak Desai(Veterans Health Administration), Samath Dhamminda Dharmaratne(University of Peradeniya), Rajkumar Doshi(St. Joseph’s University Medical Center), Islam Y. Elgendy(University of Kentucky), Valery L. Feigin(University of Washington), Irina Filip(Clinical Research Institute), Mohamed M. Gad(University of North Carolina at Chapel Hill), Sherief Ghozy(Mayo Clinic), Nima Hafezi‐Nejad(Johns Hopkins University), Rizwan Kalani(University of Washington), Ibraheem M. Karaye(Montefiore Medical Center), Adnan Kısa(Tulane University), Vijay Krishnamoorthy(Duke University), Warren Lo(Nationwide Children's Hospital), Tomislav Meštrović(University of Washington), Ted R. Miller(Curtin University), Awoke Misganaw(University of Washington), Ali H. Mokdad(University of Washington), Christopher J L Murray(University of Washington), Zuhair S. Natto(Harvard University), Amir Radfar(University of Central Florida), Pradhum Ram(University of Pittsburgh Medical Center), Gregory A. Roth(University of Washington), Allen Seylani(National Heart Lung and Blood Institute), Nilay S. Shah(Northwestern University), Purva Sharma(Kent Hospital), Aziz Sheikh(University of Edinburgh), Jasvinder A. Singh(United States Department of Veterans Affairs), Suhang Song(University of Georgia), Houman Sotoudeh(University of Alabama at Birmingham), Dominique Vervoort(Johns Hopkins University), Cong Wang(Vanderbilt University Medical Center), Hong Xiao(Fred Hutch Cancer Center), Suowen Xu(University of Science and Technology of China), Ramin Zand(Pennsylvania State University), Guido J. Falcone(Yale University), Kevin N. Sheth(Yale University)
JAMA Neurology
March 4, 2024
Cited by 108Open Access
Full Text

Abstract

Importance: Stroke is a leading cause of death and disability in the US. Accurate and updated measures of stroke burden are needed to guide public health policies. Objective: To present burden estimates of ischemic and hemorrhagic stroke in the US in 2019 and describe trends from 1990 to 2019 by age, sex, and geographic location. Design, Setting, and Participants: An in-depth cross-sectional analysis of the 2019 Global Burden of Disease study was conducted. The setting included the time period of 1990 to 2019 in the US. The study encompassed estimates for various types of strokes, including all strokes, ischemic strokes, intracerebral hemorrhages (ICHs), and subarachnoid hemorrhages (SAHs). The 2019 Global Burden of Disease results were released on October 20, 2020. Exposures: In this study, no particular exposure was specifically targeted. Main Outcomes and Measures: The primary focus of this analysis centered on both overall and age-standardized estimates, stroke incidence, prevalence, mortality, and DALYs per 100 000 individuals. Results: In 2019, the US recorded 7.09 million prevalent strokes (4.07 million women [57.4%]; 3.02 million men [42.6%]), with 5.87 million being ischemic strokes (82.7%). Prevalence also included 0.66 million ICHs and 0.85 million SAHs. Although the absolute numbers of stroke cases, mortality, and DALYs surged from 1990 to 2019, the age-standardized rates either declined or remained steady. Notably, hemorrhagic strokes manifested a substantial increase, especially in mortality, compared with ischemic strokes (incidence of ischemic stroke increased by 13% [95% uncertainty interval (UI), 14.2%-11.9%]; incidence of ICH increased by 39.8% [95% UI, 38.9%-39.7%]; incidence of SAH increased by 50.9% [95% UI, 49.2%-52.6%]). The downturn in stroke mortality plateaued in the recent decade. There was a discernible heterogeneity in stroke burden trends, with older adults (50-74 years) experiencing a decrease in incidence in coastal areas (decreases up to 3.9% in Vermont), in contrast to an uptick observed in younger demographics (15-49 years) in the South and Midwest US (with increases up to 8.4% in Minnesota). Conclusions and Relevance: In this cross-sectional study, the declining age-standardized stroke rates over the past 3 decades suggest progress in managing stroke-related outcomes. However, the increasing absolute burden of stroke, coupled with a notable rise in hemorrhagic stroke, suggests an evolving and substantial public health challenge in the US. Moreover, the significant disparities in stroke burden trends across different age groups and geographic locations underscore the necessity for region- and demography-specific interventions and policies to effectively mitigate the multifaceted and escalating burden of stroke in the country.


Related Papers

No related papers found

Powered by citation graph analysis